Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Pleiotrophin gene therapy for peripheral ischemia: evaluation of full-length and truncated gene variants.

Fang Q, Mok PY, Thomas AE, Haddad DJ, Saini SA, Clifford BT, Kapasi NK, Danforth OM, Usui M, Ye W, Luu E, Sharma R, Bartel MJ, Pathmanabhan JA, Ang AA, Sievers RE, Lee RJ, Springer ML.

PLoS One. 2013 Apr 22;8(4):e61413. doi: 10.1371/journal.pone.0061413. Print 2013.

2.

Donor myocardial infarction impairs the therapeutic potential of bone marrow cells by an interleukin-1-mediated inflammatory response.

Wang X, Takagawa J, Lam VC, Haddad DJ, Tobler DL, Mok PY, Zhang Y, Clifford BT, Pinnamaneni K, Saini SA, Su R, Bartel MJ, Sievers RE, Carbone L, Kogan S, Yeghiazarians Y, Hermiston M, Springer ML.

Sci Transl Med. 2011 Sep 14;3(100):100ra90. doi: 10.1126/scitranslmed.3002814.

3.

Injection of bone marrow cell extract into infarcted hearts results in functional improvement comparable to intact cell therapy.

Yeghiazarians Y, Zhang Y, Prasad M, Shih H, Saini SA, Takagawa J, Sievers RE, Wong ML, Kapasi NK, Mirsky R, Koskenvuo J, Minasi P, Ye J, Viswanathan MN, Angeli FS, Boyle AJ, Springer ML, Grossman W.

Mol Ther. 2009 Jul;17(7):1250-6. doi: 10.1038/mt.2009.85. Epub 2009 Apr 21.

4.

Localization of vascular response to VEGF is not dependent on heparin binding.

Springer ML, Banfi A, Ye J, von Degenfeld G, Kraft PE, Saini SA, Kapasi NK, Blau HM.

FASEB J. 2007 Jul;21(9):2074-85. Epub 2007 Feb 26.

PMID:
17325231
5.

Supplemental Content

Loading ...
Support Center